Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum HAVN Life Sciences C.HAVN

Alternate Symbol(s):  HAVLF

HAVN Life Sciences Inc is a biotechnology company engaged in the business of the research and development of psycho-pharmacological products, including the formulation of standardized psychoactive compounds derived from fungi. The products of the company will help to improve mental health and human performance.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

look into $NIRV

I'd drop this turd and look more into $NIRV, alot better management and newly listed.  rate and reply

RE:RE:RE:News Update w Radius Research and $HAVN CEO Tim Moore

hopefully these guys are not doing a 1 for 50 split like myco. What a killer that is.  rate and reply

Neovasc Announces Direct Sales Operations in United Kingdom

Fred Colen, Neovasc President and Chief Executive Officer, said, “We are pleased to expand our direct presence into the United Kingdom and want to thank our partners at Healthcare 21 for their excellent foundational efforts supporting the early growth of Reducer. We are now poised to provide even deeper support with a full-time dedicated team in the U.K. and intend to continue to invest in clinical research and field personnel to support patients, physicians, and hospitals.” ...read more

RE:RE:News Update w Radius Research and $HAVN CEO Tim Moore

Something strange going on. Price was 0.125 the day they announced share sale. Price drops to .05 before share sale closed. 2 days later share sale closes for $2mm cash injection at .087 per share and...read more

RE:News Update w Radius Research and $HAVN CEO Tim Moore

what the hell just happened with this stock price?  rate and reply

HAVN Announces Termination of Amalgamation Agreement...

to Acquire Spore Life Sciences... https://havnlife.com/havn-life-announces-termination-of-amalgamation-agreement-to-acquire-spore-life-sciences/  rate and reply

Distribution Agreement with Mycrodose Therapeutics

The Agreement allows HAVN Life to export naturally derived psilocybin from its Jamaica facility and grows roster of supply partners in the U.S. market VANCOUVER, BC, Feb. 10, 2022...read more

News Update w Radius Research and $HAVN CEO Tim Moore

News Update: HAVN Life Sciences (HAVN) w CEO Tim Moore - Mycrodose Therapeutics Distribution - https://www.youtube.com/watch?v=3vYQSR9fHcw {^youtubevideo|(width)425|(height)264|(rel)False...read more

A slow death. When to they close their doors?

No revenue, No business.   rate and reply

RE:C.HAVN News - Aquisition of US company

This is a slow to market sector. The future is solid but the time line of ONE year is realistic. Have been in the deal for some time now, had thought we would be further down the road, BUT, their are...read more

C.HAVN News - Aquisition of US company

By Shadd Dales On Feb 1, 2022 Havn Life Sciences (CNSX: HAVN) (OTCMKTS: HAVLF) CEO Tim Moore recently caught up with The Dales Report after a long absence from the podcast, with an update on the...read more

RE:Be aware of what this stock is!

Your post has me concerned. I am starting to read more background info and some of these other companies did not perform well. I am now looking to reduce my position @ a LOSS. Have listened to  ...read more

Be aware of what this stock is!

I honestly made a huge mistake investment in this shell company…fake company whatever you are.    Almost every executive and director in this company is shady and had a very dark history...read more

All directors are shady in this company

They are all previous cannabis executives who know each other and sell each other their shell companies to scan retail investors from thier money.  I've lost tons of $$$$ on the faqing...read more

I think we’ve been scammed

Guys I hate to admit it but I think we've all lost money on this POS stock...this is a definite garbage dumpster. They’ve done nothing but lose money for shareholders…all their directors have...read more

Interview Recap w Radius Research and $HAVN CEO Tim Moore

HAVN Life Sciences (HAVN) w CEO Tim Moore - HAVN Acquires Spore Life Sciences - Pitch, Interview, Discussion, Deep Dive & Q&A  - https://www.youtube.com/watch?v=uEl5yISwES0...read more

RE:Webinar w HAVN Life CEO Wed Dec 29 @ 1PM ET / 10AM PT

Perfect - looks like the promo is beginiing . Dont forget Nuefeld and his old partner , uber promoter   Andy Defraudchesco ran Aphria from nothing to hundreds of millions ,took their money...read more

Webinar w HAVN Life CEO Wed Dec 29 @ 1PM ET / 10AM PT

Webinar - HAVN Life Sciences (HAVN) w/ CEO Tim Moore Wed, Dec 29 at 1pm ET / 10am PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar/register...read more

Watch this stock pop now - just like a mushroom in the dark

This Spore group has some serious clout behind it - and its a VERY real business .  Im thinking a run to .30 by year end -maybe much more   rate and reply

Have to work through the TLS.

This company has made numerous good news announcements, BUT the share price over th past year, I started at $ .91 and it has been a losing investment from their. Got in way to early. Will see what 1st...read more

Successfully Exports Psilocybin from its Jamaica Facility

The Company Signs Supply Agreement with Nectar Health Sciences Laboratory Division Inc. to provide naturally derived psilocybin for research and development of therapeutic products VANCOUVER, BC...read more